Abstract
The novel integration of baseline clinical and microRNA variables significantly improves the long-term individualized prediction of childhood asthma remission by early adulthood compared to using clinical variables alone.
Publication types
-
Letter
-
Randomized Controlled Trial
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adolescent
-
Adult
-
Anti-Inflammatory Agents / therapeutic use*
-
Asthma / diagnosis*
-
Asthma / drug therapy
-
Asthma / genetics
-
Cytokines / metabolism
-
Double-Blind Method
-
Female
-
Humans
-
Inflammation Mediators / metabolism
-
Male
-
MicroRNAs / genetics
-
Placebo Effect
-
Prognosis
-
Th2 Cells / immunology*
-
Treatment Outcome
-
Young Adult
Substances
-
Anti-Inflammatory Agents
-
Cytokines
-
Inflammation Mediators
-
MIRN221 microRNA, human
-
MicroRNAs